Overview

An Efficacy Study of Compound LY2624803 in the Treatment of Patients With Chronic Insomnia

Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare an investigational drug (LY2624803) with placebo and with zolpidem in the treatment of outpatients with chronic insomnia.
Phase:
Phase 2
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Zolpidem